Bordet News 120 (October 2017)
Summary 3 - Edito 4 - Prévention et dépistage du cancer du sein (Dr Jean-Benoît Burrion) 6 - Vers une nouvelle prise en charge de certains cancers du sein (Françoise Rothé, DSc)
Christmas market at the Institute
from 11 to 15/12/2017, Come and discover our gift ideas for the end of year celebrations !!!
Bordet News 116 (September 2016)
Summary - La Clinique du Sein de l’Institut Jules Bordet a trente ans (Dr D. de Valeriola) - Les énormes progrès de la chirurgie (Pr J.-M. Nogaret) - De l’importance de l'Imagerie (Dr M. Radermecker)
Are you a nurse? Join the iris network!
The iris network is recruiting nursing staff!
Are you a nurse? Join the iris network!
Video iris seen from the sky
Are you a nurse? Join the iris network!
Video : iris seen from the hearth
Bordet News 121 (Decembre 2017)
Summary 3 - Edito 4 - La radiothérapie, au coeur du traitement des cancers…(Pr Dirk Van Gestel)
Best wishes 2018 !
Live life to the full in 2018!
Pr A. Awada awarded the Fonds Gaston Ithier Prize for Oncological Science
A science platform to combat brain metastases
The Department of Hematology is winner of the PACE Award from the BHS
Personalised patient follow-up during oral anticancer treatment (Press release)
Prix Fondation ARC Léopold Griffuel
Professor Martine Piccart receives the prestigious ARC Foundation Léopold Griffuel Award for translational and clinical research
Portrait of Pr Martine Piccart, award-winner of the Prix Fondation ARC Léopold Griffuel for translational and clinical research
On Thursday April 5th, the Professor Martine Piccart received the 46th Prix Fondation ARC Léopold Griffuel for translationnal and clinical research. This prestigious prize rewards annually researchers of international rewnown whose work has resulted in a major advance in cancer research.
Le CHU Bruxelles, acteur hospitalier d’envergure dans l’économie bruxelloise
1 milliard de retombées économiques et près de 7.800 emplois générés à Bruxelles en 2016.
Whether or not to participate in a clinical trial
The Jules Bordet Institute is developing an innovative digital tool to support patients in their decision-making. To develop, with the assistance of patients, a digital tool that enables patients to decide in full knowledge of the fact
Reduction of the risk of breast cancer recurrence
The administration of an anti-inflammatory drug during the ablation of the primary tumour reduces the risk of breast cancer recurrence in overweight or obese patients
Tips to avoid melanoma now that spring has sprung
We're full of the joys of spring. But be careful what it might bring! Here are a few tips to avoid melanoma now that spring has sprung.
Lambertine-Lacroix Prize - Cancerology 2018: Ch Desmedt
Prize awarded to the researcher Christine Desmedt of the Jules Bordet Institute, ULB.
The new generation of researchers doubly rewarded
Double Merit Award of the Conquer Cancer Foundation of ASCO for 2 young researchers at the Institut Jules Bordet
Oncodistinct, a multidisciplinary clinical research network
Oncodistinct, a multidisciplinary clinical research network that meets patients' needs
101 Tables pour la vie
05/06/2018 : Gastronomic evening benefiting the research laboratories of the new Institut Bordet